Uni Potent Stem Cells are a specialized type of stem cell with the unique ability to differentiate into only one specific cell type. Unlike pluripotent stem cells, which can give rise to various cell types, unipotent stem cells are committed to differentiating into a single lineage of cells. Unipotent stem cells are typically found in adult tissues and are responsible for the regeneration and maintenance of specific cell types within those tissues. Examples include myoblasts, which give rise to muscle cells, and hepatocytes, which generate liver cells. These cells play a crucial role in tissue repair and homeostasis. While unipotent stem cells are more restricted in their differentiation potential compared to pluripotent cells, they possess the advantage of being more committed to the specific needs of the tissue they reside in. This specialization allows them to contribute to tissue-specific functions with high efficiency. Researchers study unipotent stem cells to understand tissue regeneration processes and explore their therapeutic potential for tissue-specific repair. Harnessing the regenerative capabilities of unipotent stem cells may hold promise for developing targeted therapies for diseases or injuries affecting specific tissues or organs. However, much research is still needed to fully understand and unlock the therapeutic potential of unipotent stem cells.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States